recent articles

Come meet Visiopharm August 30th - September 3rd in London, UK at the 26th European Congress of Pathology. Learn about our leading image analysis Quantitative Digital Pathology solutions for research and cancer diagnostics; utilizing our...

ASI’s Webinar – July 29, 2014 – Register Now - Digital Pathology On Your Microscope A complete solution for FISH, CISH and IHC Applied Spectral Imaging Inc. develops computer aided image analysis & diagnostic tools for...

Clinical Validation Test for CISH Applied Spectral Imaging is recruiting a pathology lab to participate in a clinical validation study for HER2 CISH testing. The objective of this study is to evaluate the success of ASI’s GenASIs HiPath...

Join Visiopharm for our webinar, “HER2 Protein Expression in Breast Cancer: Membrane Morphology and Accuracy with Regard to Gene Amplification” presented by Michael Grunkin, PhD the CEO and co-founder of Visiopharm. Date:     Monday,...

Join Visiopharm for our webinar, “HER2 Protein Expression in Breast Cancer: Membrane Morphology and Accuracy with Regard to Gene Amplification” presented by Michael Grunkin, PhD the CEO and co-founder of Visiopharm. Date:     Monday,...

PITTSBURGH – April 14, 2014 – GE Healthcare and UPMC today announced that the Omnyx™ Manual Read of the Digital HER2 Application has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance will allow...

OR

platinum partners

gold partners

Silver Partners

Media Partners